Global Analysis Reveals Women Receive Less Active Treatment Than Men For Identical Health Conditions

A comprehensive new global analysis published in the journal Plos One indicates that women presenting with the same medical conditions as men are significantly less likely to be offered active treatments, including surgical interventions, stents, or strong painkillers. The review highlights widespread disparities in medical care across a range of serious health problems.

Researchers at the University of St Andrews conducted the analysis by examining 38 separate studies. Out of those evaluated, 33 studies revealed that female patients were less frequently offered active treatment compared to their male counterparts with identical diagnoses. The disparities spanned multiple medical fields, including cardiovascular conditions, kidney disease, and Parkinson's disease.

In the realm of cardiovascular health, the study found that women diagnosed with myocardial infarction, heart failure, or an irregular heartbeat were more commonly managed with medication alone. Conversely, men presenting with the same heart conditions were more likely to receive invasive procedures such as coronary bypasses, stents, or other surgical treatments. Furthermore, the analysis noted that women were less likely to be prescribed statins.

The gender discrepancy extended into other medical specialties as well. According to the findings, men suffering from Parkinson’s disease showed a higher likelihood of being referred for deep brain stimulation. Additionally, male patients experiencing liver failure were more frequently selected to receive transplants than female patients.

Renal care also exhibited notable disparities. Female kidney patients who required dialysis were less likely to be provided with permanent access, resulting in longer periods relying on catheters. In terms of emergency and comfort care, the review showed that women were less likely to be administered opioids for pain management.

Not all conditions showed a treatment gap, however. The analysis reported no significant difference between the sexes regarding treatment for stroke and diabetes. Interestingly, the research found that women were more likely to receive treatment for dementia than men.

These findings arrive amid mounting international concern regarding the persistent gender health gap. Earlier in the year, then health secretary Wes Streeting publicly stated that women were being let down by medical misogyny. Prior to that, the former Conservative government appointed Lesley Regan as England’s first women’s health ambassador specifically to help tackle systemic healthcare gaps.

Crucially, the study's authors concluded that the observed treatment discrepancies did not stem from any clinical necessity for different approaches to women’s health. The researchers determined that none of the reviewed studies identified medical guidelines recommending different treatments based on sex, pointing instead to unequal care practices.

Dr Andrew O’Malley, who co-led the study at the University of St Andrews, commented on the implications for medical professionals. He stated that the findings should serve as a prompt for clinicians to examine whether treatments are being offered strictly on clinical grounds rather than influenced by assumptions.

Dr O’Malley also pointed to existing literature demonstrating that doctors more frequently attribute women’s reported symptoms to anxiety. He noted that physicians also commit more diagnostic errors when treating female patients, even in instances where diagnostic test results return positive.

Dr Miriam Veenhuizen, an honorary lecturer in the School of Medicine at St Andrews, expressed that while the directional trend of the findings was not entirely unexpected, the sheer consistency across medical disciplines was striking. She noted that the same pattern repeatedly surfaced across cardiology, surgery, transplant medicine, and emergency care, maintaining statistical significance even after adjustments in most of the examined studies.

As the medical community continues to scrutinize these findings, future discussions will likely center on clinical training, diagnostic accuracy, and ensuring equitable intervention guidelines are rigorously followed for all patients regardless of sex.